Average Co-Inventor Count = 7.10
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rigel Pharmaceuticals, Incorporated (19 from 488 patents)
2. Cytovia, Inc. (1 from 47 patents)
3. Axys Pharmaceuticals, Inc. (1 from 40 patents)
4. Shaman Pharmaceuticals, Inc. (1 from 22 patents)
22 patents:
1. 9650391 - [object Object]
2. 9353124 - Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
3. 9206161 - Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
4. 9156820 - Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
5. 8933080 - Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
6. 8809347 - Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
7. 8809364 - Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
8. 8796259 - [object Object]
9. 8741898 - Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
10. 8658669 - [object Object]
11. 8618331 - Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
12. 8609650 - Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
13. 8492373 - Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
14. 8431594 - Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
15. 8168636 - Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors